EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Screening of Mpro Protease (SARS-CoV-2) Covalent Inhibitors from an Anthocyanin-Rich Blueberry Extract Using an HRMS-Based Analytical Platform

Alessandra Altomare iD, Giovanna Baron iD, Giulia Cambiaghi, Giulio Ferrario iD, Beatrice Zoanni, Larissa Della Vedova iD, Giulio Maria Fumagalli, Sarah D'Alessandro iD, Silvia Parapini iD, Serena Vittorio iD, Giulio Vistoli iD, Patrizia Riso iD und 3 weitere

Molecules · 2024

DOI: 10.3390/molecules29112702 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Alessandra Altomare und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences (DISFARM), Università degli Studi di Milano, Via Mangiagalli 25, 20133 Milan, Italy. Hauptthemen laut MEDLINE: Blueberry Plants, Anthocyanins, Antiviral Agents, SARS-CoV-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Regione Lombardia, Ministero dell’Università e della Ricerca PON “Ricerca e Innovazione” 2014–2020, Azione IV.4—“Dottorati e contratti di ricerca su tematiche dell’innovazione”, Azione IV.6—“Contratti di ricerca su tematiche Green”.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The viral main protease (Mpro) of SARS-CoV-2 has been recently proposed as a key target to inhibit virus replication in the host. Therefore, molecules that can bind the catalytic site of Mpro could be considered as potential drug candidates in the treatment of SARS-CoV-2 infections. Here we proposed the application of a state-of-the-art analytical platform which combines metabolomics and protein structure analysis to fish-out potential active compounds deriving from a natural matrix, i.e., a blueberry extract.

Methods

The experiments focus on finding MS covalent inhibitors of Mpro that contain in their structure a catechol/pyrogallol moiety capable of binding to the nucleophilic amino acids of the enzyme’s catalytic site.

Results

Among the potential candidates identified, the delphinidin-3-glucoside showed the most promising results. Its antiviral activity has been confirmed in vitro on Vero E6 cells infected with SARS-CoV-2, showing a dose-dependent inhibitory effect almost comparable to the known Mpro inhibitor baicalin. The interaction of delphinidin-3-glucoside with the Mpro pocket observed was also evaluated by computational studies.

Conclusions

The HRMS analytical platform described proved to be effective in identifying compounds that covalently bind Mpro and are active in the inhibition of SARS-CoV-2 replication, such as delphinidin-3-glucoside.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blueberry PlantsAnthocyaninsAntiviral AgentsSARS-CoV-2Plant ExtractsProtease InhibitorsCoronavirus 3C ProteasesChlorocebus aethiopsVero CellsAnimalsCOVID-19 Drug TreatmentHumansMolecular Docking SimulationCOVID-19Glucosides

Stichwörter der Autor:innen

MproSARS-CoV-2blueberrydelphinidin-3-glucosidemass spectrometrymetabolomics

Substanzen

AnthocyaninsAntiviral AgentsPlant ExtractsProtease InhibitorsCoronavirus 3C Proteasesdelphinidin 3-O-glucopyranosideblueberry extractGlucosides

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences (DISFARM), Università degli Studi di Milano, Via Mangiagalli 25, 20133 Milan, Italy.
  • Unitech OMICs, Università degli Studi di Milano, Viale Ortles 22/4, 20139 Milan, Italy.
  • Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Via Carlo Pascal 36, 20133 Milan, Italy.
  • Department of Biomedical Sciences for Health, Università degli Studi di Milano, Via Carlo Pascal 36, 20133 Milan, Italy.
  • Department of Food, Environmental and Nutritional Sciences, Università degli Studi di Milano, Via Luigi Mangiagalli 25, 20133 Milan, Italy.
  • Department of Biomedical, Surgical and Dental Sciences, Università degli Studi di Milano, Via Carlo Pascal 36, 20133 Milan, Italy.

ORCID-Profile: Alessandra Altomare, Giovanna Baron, Giulio Ferrario, Larissa Della Vedova, Sarah D'Alessandro, Silvia Parapini, Serena Vittorio, Giulio Vistoli, Patrizia Riso, Serena Delbue, Giancarlo Aldini

Förderung

  • Regione Lombardia
  • Ministero dell’Università e della Ricerca PON “Ricerca e Innovazione” 2014–2020, Azione IV.4—“Dottorati e contratti di ricerca su tematiche dell’innovazione”
  • Azione IV.6—“Contratti di ricerca su tematiche Green”
  • POR FESR 2014–2020_BANDO Call HUB Ricerca e Innovazione, Regione Lombardia
  • UNIMI GSA-IDEA project

Zitieren

APA

Altomare, A., Baron, G., Cambiaghi, G., Ferrario, G., Zoanni, B., Della Vedova, L., Fumagalli, G. M., D'Alessandro, S., Parapini, S., Vittorio, S., Vistoli, G., Riso, P., Carini, M., Delbue, S., & Aldini, G. (2024). Screening of Mpro Protease (SARS-CoV-2) Covalent Inhibitors from an Anthocyanin-Rich Blueberry Extract Using an HRMS-Based Analytical Platform. Molecules. https://doi.org/10.3390/molecules29112702

Vancouver

Altomare A, Baron G, Cambiaghi G, Ferrario G, Zoanni B, Della Vedova L, et al. Screening of Mpro Protease (SARS-CoV-2) Covalent Inhibitors from an Anthocyanin-Rich Blueberry Extract Using an HRMS-Based Analytical Platform. Molecules. 2024. doi:10.3390/molecules29112702

BibTeX
@article{Altomare2024,
  author = {Altomare, Alessandra and Baron, Giovanna and Cambiaghi, Giulia and Ferrario, Giulio and Zoanni, Beatrice and Della Vedova, Larissa and Fumagalli, Giulio Maria and D'Alessandro, Sarah and Parapini, Silvia and Vittorio, Serena and Vistoli, Giulio and Riso, Patrizia and Carini, Marina and Delbue, Serena and Aldini, Giancarlo},
  title = {Screening of Mpro Protease (SARS-CoV-2) Covalent Inhibitors from an Anthocyanin-Rich Blueberry Extract Using an HRMS-Based Analytical Platform},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29112702}
}
Kostenlos starten →